Background: SIGLEC family genes can also be expressed on tumor cells in different cancer types, and though it has been found that SIGLEC genes expressed by immune cells can be exploited by tumors to escape immune surveillance, functions of tumor derived SIGLEC expression in tumor microenvironment (TME) were barely investigated, which could play roles in cancer patients' survival.
Methods: Using bioinformatic analysis, mutation status of SIGLEC family genes was explored through the cBioPortal database, and expression of them in different tumors was explored through the UALCAN database. The GEPIA database was used to compare SIGLEC family genes' mRNA between cancers and to generate a highly correlated gene list in tumors. A KM-plotter database was used to find the association between SIGLEC genes and survival of patients. The associations between SIGLEC family genes' expression, immune infiltration, and immune regulators' expression in TME were generated and examined by the TIMER 2.0 database; the differential fold changes of SIGLEC family genes in specific oncogenic mutation groups of different cancer types were also yielded by TIMER 2.0. The networks of SIGLEC family genes and highly correlated genes were constructed by the STRING database, and gene ontology and pathway annotation of SIGLEC family highly correlated genes were performed through the DAVID database.
Results: SIGLEC family genes were highly mutated and amplified in melanoma, endometrial carcinoma, non-small cell lung cancer, bladder urothelial carcinoma, and esophagogastric adenocarcinoma, while deep deletion of SIGLEC family genes was common in diffuse glioma. Alteration of SIGLEC family genes demonstrated different levels in specific tumors, and oncogenic mutation in different cancer types could influence SIGLEC family genes' expression. Most SIGLEC family genes were related to patients' overall survival and progression free survival. Also, tumor derived SIGLEC family genes were related to tumor immune cell infiltration and may regulate TME by influencing chemokine axis.
Conclusion: Our computational analysis showed SIGLEC family genes expressed by tumor cells were associated with tumor behaviors, and they may also influence TME through chemokine axis, playing vital roles in patients' survival. Further experiments targeting tumor derived SIGLEC family genes are needed to confirm their influences on tumor growth, metastasis, and immune environment regulation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681003 | PMC |
| http://dx.doi.org/10.3389/fonc.2020.586820 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Siglecs-mediated immune regulation in neurological disorders.
Pharmacol Res
December 2024
Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China. Electronic address:
Article Synopsis
- * There is limited research on Siglecs in the context of neurological disorders, despite their importance in the development and repair of the nervous system.
- * This review highlights the immunomodulatory functions of Siglecs in neurological conditions, the impact of dysregulated sialic acid on psychiatric disorders, and the current limitations in therapeutic research.
The glycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9.
Leukemia
November 2024
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Immunotherapy has demonstrated promise as a treatment for acute myeloid leukemia (AML). However, there is still an urgent need to identify new molecules that inhibit the immune response to AML. Most prior research in this area has focused on protein-protein interaction interfaces.
View Article and Find Full Text PDFSiglec-15 as a potential molecule involved in osteoclast differentiation and bone metabolism.
Heliyon
November 2024
Department of Orthodontics, Medical Center of Stomatology, The Second Xiangya Hospital, Central South University, Furong District, Changsha, Hunan, 410011, China.
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is a well-conserved type I transmembrane protein of the Siglecs family, distributed in macrophages and dendritic cells in the human spleen and lymph nodes. As an immune receptor, Siglec-15 is expressed in almost all branches of the spinal cord. Siglec-15 participates in the metabolism of the skeleton by regulating osteoclast activity and differentiation and has an influential role in dynamic bone remodelling.
View Article and Find Full Text PDFFunctional characterization of Siglec14 in facilitating innate defenses in Carassius cuvieri × Carassius auratus red var.
Fish Shellfish Immunol
December 2024
State Key Laboratory of Developmental Biology of Freshwater Fish, Engineering Research Center of Polyploid Fish Reproduction and Breeding of the State Education Ministry, College of Life Sciences, Hunan Normal University, Changsha, 410081, Hunan, China; Guangdong Provincial Key Laboratory of Aquatic Animal Disease Control and Healthy Culture, Guangdong Ocean University, Zhanjiang, 524088, Guangdong, China. Electronic address:
Sialic acid-binding Ig-like lectin 14 (Siglec14) is a member of the Siglecs family, a group of immune system receptors characterized by their ability to recognize sialic acids, which are a type of carbohydrate commonly found on the surfaces of cells in mammals. However, the role of Siglec14 in the innate immunity of teleosts has not been extensively explored. For this purpose, our study focused on the identification and characterization of a classical Siglec14, designated as WR-Siglec14, derived from the hybrid fish Carassius cuvieri × Carassius auratus red var.
View Article and Find Full Text PDFA human lectin array for characterizing host-pathogen interactions.
J Biol Chem
November 2024
Department of Life Sciences, Imperial College London, London, United Kingdom. Electronic address:
Article Synopsis
- A human lectin array has been developed to study how immune receptors interact with various microbes, featuring C-type carbohydrate-recognition domains (CRDs) and other sugar-binding receptors like galectins and siglecs.
- The array is designed using biotin-tagged CRDs, allowing for easy detection of binding interactions on a streptavidin-coated surface, facilitating comparisons across different types of glycan-binding receptors.
- Initial tests show unexpected binding patterns, revealing that some galectins interact strongly with bacterial glycans, highlighting the array's potential to provide new insights into innate immune interactions with diverse microorganisms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!